In a promising development, researchers announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).
A team of researchers at Baylor College of Medicine and Roswell Park Comprehensive Cancer Center has identified a long sought after connection between how cancer cells use glucose to generate energy and cancer growth.
Dr. Jeffrey A. Bluestone, the A.W. and Mary Margaret Clausen Distinguished Professor at the University of California San Francisco, will be the Distinguished Lecturer at the Seventh Annual McNair Symposium at Baylor College of Medicine.
The Department of Molecular and Human Genetics and the Dan L Duncan Comprehensive Cancer Center hosted their first joint U.S.-Japan Clinical Cancer Genomics and Personalized Medicine Symposium in Tokyo, Japan.
The physical and emotional tolls chemotherapy can have on a patient undergoing cancer treatment are well known, but there are many myths when it comes to managing fitness and nutrition during treatment. Nutritionist Rachel Dudley explains.
Researchers at Baylor College of Medicine have received $3,568,639 from the Cancer Prevention and Research Institute of Texas for three new grants focused on tobacco control, cancer screening and novel treatments for cancer in children and adults
A multidisciplinary team of scientists has been shortlisted to the final stages of Cancer Research UK’s Grand Challenge, an ambitious series of £20 million global grants tackling some of the toughest questions in cancer research.
The NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is hosting a free educational program for cancer patients and their caregivers seeking to learn more about cancer immunotherapy and clinical trials.
Dr. Stephen Mack and colleagues have developed a framework for discovering targets in ependymomas, and other cancer that lack known genetic drivers, thereby also providing insights into treatment strategies.
Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future.
Dr. Trey Westbrook has been named the newest McNair Scholar. This recognition will support his work focused on discovering the genes and mechanisms that drive breast cancer and developing the next generation of cancer medicines.